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abstract  A perforated-patch whole-cell recording method was used to determine whether nitric oxide signal-
ing participates in acetylcholine (ACh)-induced regulation of basal L-type Ca2� current (ICa,L) in cat atrial myo-
cytes. Exposure to 1 �M ACh for 2 min inhibited basal ICa,L (�21 � 3%), and withdrawal of ACh elicited rebound 
stimulation of ICa,L above control (80 � 13%) (n � 23). Stimulation of ICa,L elicited by withdrawal of ACh (but not 
ACh-induced inhibition of ICa,L) was blocked by either 50 �M hemoglobin; 30 �M ODQ or 10 �M methylene blue, 
inhibitors of soluble guanylate cyclase; 10 �M W-7, a calmodulin inhibitor; or 10 �M L-NIO, an inhibitor of consti-
tutive NO synthase (NOS). In cells incubated in 5 mM L-arginine, ACh-induced rebound stimulation of ICa,L was 
enhanced compared with control responses. Histochemical assay (NADPH diaphorase) indicated that atrial myo-
cytes express constitutive NOS. NO-donor, spermine/NO (SP/NO), �1 �M stimulated basal ICa,L. SP/NO-induced 
stimulation of ICa,L was inhibited by 50 �M hemoglobin, 30 �M ODQ, or 5 �M H-89, an inhibitor of PKA, and was 
unchanged by 50 �M MnTBAP, a peroxynitrite scavenger. When ICa,L was prestimulated by 10 �M milrinone, an 
inhibitor of cGMP-inhibited phosphodiesterase (type III) activity, SP/NO failed to further increase ICa,L. In cells 
incubated in pertussis toxin (3.4 �g/ml for 6 h; 36�C), ACh failed to affect ICa,L, but 100 �M SP/NO or 10 �M mil-
rinone still increased basal ICa,L. These results indicate that in cat atrial myocytes NO signaling mediates stimula-
tion of ICa,L elicited by withdrawal of ACh but not ACh-induced inhibition of basal ICa,L. NO activates cGMP-induced 
inhibition of phosphodiesterase (type III) activity. Upon withdrawal of ACh, this mechanism allows cAMP to re-
cover to levels above control, thereby stimulating ICa,L. Pertussis toxin–sensitive G-proteins couple M2 muscarinic 
receptors to NO signaling. NO-mediated stimulation of ICa,L elicited by withdrawal of ACh may be an important 
mechanism that rapidly restores cardiac pacemaker and contractile functions after cholinergic suppression of 
atrial activity. 
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introduction	 tion of cardiac function is enhanced by earlier �-adrener-
Nitric oxide is an important second messenger that me- gic stimulation. 
diates a variety of cardiovascular functions (Kelly et al.,  Previous work has shown that in cat atrial myocytes 
1996), including cholinergic regulation of cardiac ICa,L 
exposure to ACh inhibits basal ICa,L and withdrawal of 
ACh elicits a prominent rebound stimulation of ICa,L (Han et al., 1994, 1995, 1996; Balligand et al., 1995; 
above control (Wang and Lipsius, 1995). Rebound Habuchi et al., 1996). For example, in the sinoatrial 
node (Han et al., 1995) or atrioventricular node (Han  stimulation of ICa,L elicited by ACh withdrawal is re-
et al., 1996) cells, acetylcholine (ACh)1 inhibits pre- sponsible for stimulation of atrial contractile (Wang 
stimulated ICa,L via NO signaling mechanisms that acti- and Lipsius, 1995) and pacemaker activities (Wang and 
Lipsius, 1996) above control, and can lead to the devel- vate cGMP-induced stimulation of phosphodiesterase 
opment of dysrhythmic atrial activity (Wang et al., (PDE) activity. This mechanism is thought to contrib-
ute to accentuated antagonism, where cholinergic inhibi- 1997). A primary mechanism mediating the stimulatory 
effects of ACh withdrawal is a rebound increase in 
cAMP resulting from ACh-induced inhibition of PDE 
(type III) activity (Wang and Lipsius, 1995). Although 
NO-cGMP signaling is known to modulate PDE activity 
(Fischmeister and Mery, 1996), it is not known to what 
†Ms. Rechenmacher died on 17 August 1997.	 extent, if any, NO signaling contributes to ACh-induced 
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nue, Maywood, IL 60153. Fax: 708-216-6308; E-mail: slipsiu@wpo.it.  whether NO signaling participates in ACh-induced reg- luc.edu 
1Abbreviations used in this paper: Ach, acetylcholine; PDE, phospho- ulation of ICa,L, especially in relation to stimulation of 
diesterase; PTX, pertussis toxin; SP/NO, spermine/NO.  ICa,L elicited by withdrawal of ACh. 
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Cell Isolation 
Details of the isolation and recording methods have been pub-
lished previously (Wang and Lipsius, 1995). Atrial myocytes were 
isolated from cat heart. Adult cats of either sex were anesthetized 
with sodium pentobarbital (70 mg/kg i.p.). Hearts were perfused 
via a Langendorff apparatus with a bicarbonate-buffered Tyrode 
solution for �5 min, followed by perfusion with a nominally 
Ca2�-free Tyrode solution. After 5 min, the perfusion was 
switched to a low (36 �M) Ca2� Tyrode solution containing 
0.06% collagenase (type II; Worthington Biochemical Corp., 
Freehold, NJ) for 30–40 min. After collagenase perfusion, both 
atria were cut into small pieces and agitated in fresh collagenase 
and 0.01% protease. Experiments were performed on either 
right or left atrial cells, with no discernible differences. Cells 
studied were isolated on the morning of the experiment. 
Electrophysiological Recording Methods 
Cells used for study were transferred to a small tissue bath on the 
stage of an inverted microscope (Nikon Diaphot; Nikon Inc., 
Melville, NY) and superfused with a modified Tyrode solution 
containing (mM): 137 NaCl, 5.4 KCl, 1.0 MgCl2, 2.5 CaCl2, 5 
HEPES, and 11 glucose, titrated with NaOH to a pH of 7.4. Solu-
tion was perfused through a small (0.3 ml) chamber by gravity at 
�5 ml/min. The system required �20 s to completely exchange 
the bath contents. All experiments were performed at 35 � 1�C. 
Cells selected for study were elongated and quiescent. Ionic cur-
rents were recorded using a nystatin-perforated patch (Horn and 
Marty, 1988) whole-cell recording method (Hamill et al., 1981). 
This method minimizes dialysis of intracellular contents with the 
internal pipette solution, thereby maintaining physiological buff-
ering of intracellular Ca2� and second messenger signaling path-
ways (Zhou and Lipsius, 1993). Nystatin was dissolved in DMSO 
at a concentration of 50 mg/ml, and then added to the internal 
pipette solution to yield a final nystatin concentration of 150 �g/ 
ml. The pipette solution containing nystatin is strongly sonicated 
before use. The internal pipette solution contained (mM): 100 
Cs-glutamate, 40 CsCl, 1.0 MgCl2, 4 Na2-ATP, 0.5 EGTA, 5 
HEPES, titrated with CsOH to a pH of 7.2. To record ICa,L, ACh-
activated K� currents were blocked by Cs� in the internal pipette 
solution and 20 mM CsCl in the external solution. Addition of 
CsCl to the external solution was not osmotically compensated. If 
ACh elicited changes in background K� conductance, the cell 
was discarded. 
A single suction pipette was used to record ionic currents (dis-
continuous voltage clamp mode) using an Axoclamp 2A ampli-
fier (Axon Instruments, Inc., Foster City, CA). Once a gigaseal 
was formed, the access resistance was monitored until it stabi-
lized, which generally required �5 min. In the voltage clamp 
mode, the amplifier sampling rate was �10–12 kHz. A second 
scope was used to monitor the duty cycle to ensure complete set-
tling of the voltage transient between samples. Computer soft-
ware (pCLAMP; Axon Instruments, Inc.) was used to deliver volt-
age protocols and acquire and analyze data. In addition, all sig-
nals were digitally recorded on VCR tape. 
In general, ICa,L was activated by clamping cells from a holding 
potential of �40 mV, to inactivate fast Na� channels, to 0 mV for 
200 ms every 5 s. Peak ICa,L was measured with respect to steady 
state current and was not compensated for leak currents. Cells 
were exposed to ACh for 2 min to elicit maximum rebound stim-
ulation of ICa,L. Consecutive exposures to ACh were performed at 
least 5 min apart to avoid any potential effects of desensitization. 
Preliminary experiments indicate that this time interval allowed 
reproducible effects of two consecutive ACh exposures on ICa,L. 
Raw data were analyzed for statistical significance using paired 
and unpaired Student’s t tests and considered significant at P � 
0.05. Data are expressed as mean � SEM. In several experiments, 
the effects of ACh on ICa,L were tested in the absence and then 
presence of a drug or compound that alters NO signaling. The 
percent change in ICa,L induced by ACh in the presence of a drug 
or compound was determined in relation to the new baseline 
ICa,L established by the drug or compound. The animal proce-
dures used in this study were in accordance with the guidelines of 
the Animal Care and Use Committee of Loyola University Medi-
cal Center. 
Histochemical Methods 
A histochemical assay (NADPH-diaphorase), as described previ-
ously (Prabhakar et al., 1993), was used to determine whether 
atrial myocytes express NOS activity. After cells were isolated, 
they were plated on microscope slides treated with laminin 
(Sigma Chemical Co., St. Louis, MO). Then cells were fixed by 
10% formalin and washed in PBS at pH 7.4. Fixed cells from the 
same hearts were incubated for 1 h in PBS containing 0.3% Tri-
ton X-100, and 0.2 mM nitro blue tetrazolium, either in the ab-
sence (control) or presence of �-NADPH. In the presence of 
�-NADPH, NOS reduces tetrazolium to formazan, which appears 
as a dark blue stain. 
Drugs and Chemicals 
Drugs and chemicals included acetylcholine chloride (Sigma 
Chemical Co.), H-89 (N-[2-p-bromocinnamylamino]-5-isoquino-
linesulfonamide) (Seikagaku America, Inc., Rockville, MD), 
MnTBAP (Mn tetrakis [4-benzoic acid] porphyrin chloride) (Cal-
biochem Corp., La Jolla, CA), hemoglobin (Sigma Chemical Co.), 
globin (Sigma Chemical Co.), W-7 (N-(6-aminohexyl)-5-chloro-
1-naphthalenesulfonamide hydrochloride) (Sigma Chemical Co.), 
ODQ (1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one) (Sigma Chem-
ical Co.), l-arginine and d-arginine (Sigma Chemical Co.); L-NIO 
(l-N5-(1-iminoethyl)-ornithine (Alexis Corp., San Diego, CA) 
and spermine/NO (Research Biochemicals, Inc., Natick, MA). 
Stock solutions of H-89 and ODQ were prepared in DMSO. Final 
DMSO concentrations were �0.05% and had no effect on basal 
ICa,L. Spermine/NO solutions were prepared fresh for each ex-
periment and were not used for more than �1 h. 
results 
ACh-induced Inhibition and Rebound Stimulation of ICa,L 
Fig. 1, A and B illustrates the effects of ACh exposure 
and withdrawal on selected recordings of ICa,L (A) and 
consecutive measurements of peak ICa,L (B) obtained 
from a single atrial myocyte. Under control conditions, 
exposure to 1 �M ACh for 2 min inhibited ICa,L by 36%. 
Within 30 s of withdrawing ACh, ICa,L amplitude exhib-
ited a prominent rebound stimulation of 141% above 
control. ICa,L required �4–5 min to return to a stable 
baseline. Similar ACh-induced changes in ICa,L have 
been reported previously (Wang and Lipsius, 1995). As 
shown in Fig. 1 B, after the initial ACh exposure peak, 
ICa,L generally stabilized at a level higher than the con-
trol baseline level. In other words, peak ICa,L did not al-
ways fully recover from the stimulatory effects of ACh 
withdrawal even though the current reached a stable 
level. This was more evident when the rebound stimula-
114  NO Signaling and Cholinergic Regulation of ICa,L Figure 1.  Effect of hemoglobin on ACh-induced regulation of 
ICa,L (A) and consecutive measurements of peak ICa,L amplitude 
throughout the same experiment (B). Under control conditions, 
exposure to 1 �M ACh inhibited ICa,L and withdrawal of ACh elic-
ited a prominent rebound stimulation of ICa,L. Hemoglobin (50 
�M) in the external solution decreased ICa,L to control levels. In 
the presence of hemoglobin, ACh inhibited ICa,L, but rebound 
stimulation of ICa,L was abolished. All recordings were obtained 
from the same cell. 
tory response was relatively large. This will be discussed 
in more detail below. The main focus of this study was 
to determine whether the ACh-induced changes in basal 
ICa,L are mediated via NO signaling mechanisms. 
Effects of Hemoglobin on ACh-induced Regulation of ICa,L 
If ACh regulates ICa,L via production of NO then hemo-
globin, a well known scavenger of NO, should inhibit 
ACh-induced effects that are mediated by NO. Even 
though hemoglobin is restricted to the external space, 
because of its very high affinity for NO (Gibson and 
Roughton, 1957), hemoglobin can inhibit intracellular 
NO signaling mechanisms by acting as a “sink” for in-
tracellular NO (Beasley et al., 1991; Balligand et al., 
1993, 1995). We therefore tested ACh in the presence 
of hemoglobin. As shown in Fig. 1, A and B, once ICa,L 
stabilized after the initial ACh exposure, exposure to 
50 �M hemoglobin decreased ICa,L (�35%) to control 
baseline levels. In the presence of hemoglobin, ACh 
decreased ICa,L by 40% and rebound stimulation of ICa,L 
elicited by withdrawal of ACh was essentially abolished 
(8%). In a total of five cells tested, in the absence and 
presence of 50 �M hemoglobin, ACh decreased ICa,L by 
21  � 5% and 20 � 6%, respectively, and ACh with-
drawal stimulated ICa,L by 106 � 21% and 13 � 6%, re-
spectively, a reduction of 88% (P � 0.02). Hemoglobin 
alone decreased ICa,L amplitude (�22 � 5%) to a value 
that was not different from baseline control levels. In 
four additional cells, lowering the hemoglobin concen-
tration to 10 �M blocked stimulation of ICa,L elicited by 
ACh withdrawal by 50%, without affecting ACh-induced 
inhibition of ICa,L. Moreover, in three additional cells 
we found that 10 �M globin had no effect on basal ICa,L 
or ACh-induced rebound stimulation of ICa,L, suggest-
ing that the effects of hemoglobin were due to the 
binding of NO. These findings indicate that NO signal-
ing is essential for rebound stimulation of ICa,L elicited 
by ACh withdrawal but does not contribute to ACh-
induced inhibition of basal ICa,L. 
ACh-induced NO Acts via cGMP Signaling 
A common pathway for NO signaling is through activa-
tion of soluble guanylate cyclase and the production of 
cGMP (Fischmeister and Mery, 1996). We therefore 
tested the effects of ACh in the absence and presence 
of ODQ, a potent and selective inhibitor of soluble gua-
nylate cyclase activity (Brunner et al., 1996; Garthwaite 
et al., 1995). As shown in Fig. 2 A, under control condi-
tions, 1 �M ACh elicited a typical inhibition of ICa,L 
(�16%) and was followed, upon withdrawal of ACh, by 
stimulation of ICa,L (60%) above control. Exposure to 
30 �M ODQ alone slightly increased ICa,L (3%). In the 
presence of ODQ, ACh inhibited ICa,L by 22% and re-
bound stimulation of ICa,L was abolished. In a total of 
four cells tested, in the absence and presence of ODQ, 
ACh-induced inhibition of ICa,L was 16 � 8% and 28 � 
8%, respectively, and stimulation of ICa,L elicited by 
withdrawal of ACh was 95 � 33% and 5 � 6%, respec-
tively (P � 0.02). ODQ alone increased ICa,L by 9 � 4%. 
Fig. 2 B shows the effects of 10 �M methylene blue, a 
relatively nonselective and weak inhibitor of soluble 
guanylate cyclase (Mayer et al., 1993), on the responses 
to ACh. Under control conditions, exposure to 1 �M 
ACh inhibited ICa,L  (�20%) and withdrawal of ACh 
stimulated ICa,L (116%). Exposure to methylene blue 
alone slightly increased ICa,L. In the presence of methyl-
ene blue, ACh induced inhibition of ICa,L (�34%) and 
withdrawal of ACh failed to stimulate ICa,L. In the four 
cells tested, in the absence and presence of methylene 
blue, ACh-induced inhibition of ICa,L was 11 � 3% and 
115  Wang et al. 30 � 3%, respectively (P � 0.005), and withdrawal of 
ACh changed ICa,L by 143 � 37% and �7 � 0.3%, re-
spectively (P � 0.05). These findings provide further 
support for the idea that ACh-induced NO acts via solu-
ble guanylate cyclase and presumably cGMP signaling 
to mediate rebound stimulation of ICa,L elicited by with-
drawal of ACh. Moreover, they indicate that NO-cGMP 
signaling does not mediate ACh-induced inhibition of 
basal ICa,L. 
NOS Mediates ACh-induced Rebound Stimulation of ICa,L 
If ACh acts via NO signaling then inhibition of constitu-
tive NOS should block ACh-induced changes in ICa,L 
mediated by NO. In Fig. 3, A and B, we tested the effect 
of L-NIO, an inhibitor of constitutive NOS (Rees et al., 
1990) on ACh-induced regulation of ICa,L. The left por-
tion of Fig. 3 A shows control responses to ACh expo-
sure and withdrawal; inhibition (�18%) followed by 
prominent rebound stimulation of ICa,L (74%). After 
recovery from ACh, exposure to 10 �M L-NIO alone 
decreased ICa,L by 20%. In the presence of L-NIO, reex-
posure to ACh still inhibited ICa,L (�16%) but rebound 
stimulation of ICa,L was abolished. In the five cells 
tested, in the absence and presence of L-NIO (Fig. 3 
B), ACh inhibited ICa,L by 19 � 5% and 23 � 8%, re-
Figure 2.  Effects of ODQ (A) and methylene 
blue (B), inhibitors of soluble guanylate cyclase, 
on ACh-induced regulation of ICa,L. Each graph 
shows consecutive measurements of peak ICa,L am-
plitude. Effects of ODQ (A). Under control con-
ditions, ACh (1 �M) exposure and withdrawal 
elicited inhibition and rebound stimulation of 
ICa,L, respectively. Exposure to 30 �M ODQ elic-
ited a small increase in ICa,L. In the presence of 
ODQ, ACh-induced inhibition of ICa,L was en-
hanced and rebound stimulation of ICa,L was 
abolished. Effects of methylene blue (B). Under 
control conditions, ACh (1 �M) exposure and 
withdrawal elicited inhibition and rebound stimu-
lation, respectively, of ICa,L. Methylene blue (10 
�M) elicited a small increase in ICa,L. In the pres-
ence of methylene blue, ACh-induced inhibition 
of ICa,L was enhanced and rebound stimulation of 
ICa,L was abolished. Measurements of ICa,L were ob-
tained from two different cells. 
spectively, and withdrawal of ACh stimulated ICa,L by 
111  �  38% and 1 � 7%, respectively (P � 0.02). L-NIO 
alone decreased ICa,L amplitude by 28 � 5%. As noted 
earlier, after withdrawal of the initial exposure to ACh, 
ICa,L did not fully recover to its original control level. 
Therefore, the effect of L-NIO alone simply decreased 
ICa,L back to control baseline levels. These results sug-
gest that ACh-induced activation of constitutive NOS 
mediates rebound stimulation of ICa,L but not inhibi-
tion of ICa,L. If L-NIO blocked ACh-induced rebound 
stimulation of ICa,L by specifically inhibiting NOS activ-
ity, then elevated levels of l-arginine, the substrate used 
by NOS to synthesize NO (Mayer, 1995), should restore 
the effect of ACh. Therefore, in four additional cells we 
tested ACh in the presence of 10 �M L-NIO in cells in-
cubated (3 h) in 5 mM l-arginine. Under these condi-
tions, ACh elicited a typical rebound stimulation of ICa,L 
(65 � 4%). 
Calmodulin-dependent NOS Mediates ACh-induced 
NO Signaling 
Activation of constitutive NOS activity is Ca-calmodulin 
dependent (Bredt and Snyder, 1990). If ACh-induced 
activation of NO signaling is mediated via constitutive 
NOS, then rebound stimulation of ICa,L elicited by ACh 
116  NO Signaling and Cholinergic Regulation of ICa,L Figure 3.  Effect of L-NIO, an inhibitor of constitutive NOS, on 
ACh-induced regulation of ICa,L. A shows consecutive measure-
ments of peak ICa,L amplitude, and B shows percent changes of 
ACh-induced inhibition and rebound stimulation of ICa,L in the ab-
sence (open bar) and presence (striped bar) of 10 �M L-NIO (n � 
5). Under control conditions, ACh exposure induced inhibition 
and ACh withdrawal induced rebound stimulation of ICa,L. L-NIO 
alone decreased ICa,L. In the presence of L-NIO, ACh inhibited 
ICa,L and rebound stimulation of ICa,L was abolished. *P � 0.02. 
withdrawal should be blocked by inhibition of calmod-
ulin. This idea was examined by testing the effects of 
ACh in the absence and then presence of W-7, a potent 
inhibitor of calmodulin (Hidaka et al., 1981; Asano, 
1989). As shown in Fig. 4, A and B, under control con-
ditions (A), 1 �M ACh induced a typical inhibition 
(�20%), and was followed, upon withdrawal of ACh, by 
a prominent stimulation of ICa,L (89%). After recovery 
from ACh, the cell was exposed to 10 �M W-7 (Fig. 4 
B), which decreased ICa,L (�8%) to the control level. In 
the presence of W-7, ACh inhibited ICa,L (�17%) and 
stimulation of ICa,L typically elicited by withdrawal of 
ACh was essentially abolished. In the four cells tested, 
in the absence and presence of 10 �M W-7, ACh inhib-
ited ICa,L by 16 � 3% and 16 � 4%, respectively, and 
withdrawal of ACh stimulated ICa,L by 60 � 18% and 
6 � 8%, respectively (P � 0.02). W-7 alone decreased 
ICa,L by 10 � 2%, bringing ICa,L amplitude to the control 
baseline level. These findings further support the con-
clusion that a constitutive Ca-calmodulin-dependent 
NOS mediates ACh-induced rebound stimulation of 
ICa,L and does not mediate ACh-induced inhibition of 
ICa,L. 
Effect of l-arginine on ACh-induced NO Signaling 
As noted earlier, l-arginine is the substrate used by 
NOS to synthesize NO (Mayer, 1995). If NO signaling 
participates in ACh-induced regulation of ICa,L, then ex-
posure to a relatively high concentration of l-arginine 
should accentuate the stimulatory response elicited by 
ACh withdrawal. In one approach, we tested 1 �M ACh 
in the absence and presence of 5 mM l-arginine in the 
same cell. The cell was acutely exposed to l-arginine 
for 8 min between the first and second exposures to 
ACh. In the absence of l-arginine, ACh decreased ICa,L 
by 21 � 5% and withdrawal of ACh stimulated ICa,L by 
49 � 6% (not shown). Exposure to l-arginine elicited a 
small decrease in ICa,L  (�13  �  6%). After 8 min in 
l-arginine, a second exposure to ACh inhibited ICa,L by 
23 � 4% and withdrawal of ACh stimulated ICa,L by 
73  � 13% (n � 8). Although the stimulation of ICa,L 
elicited by ACh withdrawal was enhanced, it did not 
reach statistical significance (P � 0.09). It seemed pos-
sible that an 8-min exposure to l-arginine was not long 
enough to significantly raise intracellular l-arginine 
concentrations. Therefore, in a second approach, we 
incubated atrial myocytes in 5 mM l-arginine for at 
least 3 h before testing their response to ACh. Cells in-
cubated in l-arginine for 3 h and those cells exposed to 
l-arginine for 8 min were obtained from the same two 
hearts. Cells incubated in l-arginine (3 h) exhibited 
basal ICa,L amplitudes not significantly different from 
control cells. Fig. 5, A and B shows original ICa,L traces 
from a typical experiment. In a cell not incubated in 
l-arginine (Fig. 5 A), exposure to ACh induced inhibi-
tion and withdrawal of ACh induced stimulation of ICa,L 
(49%). In another cell incubated in l-arginine (Fig. 5 
B), ACh-induced inhibition of ICa,L was similar to con-
trol, but stimulation of ICa,L elicited by withdrawal of 
ACh was enhanced (98%). In a total of six cells incu-
bated in l-arginine, exposure to ACh decreased ICa,L by 
11 � 5% and withdrawal of ACh stimulated ICa,L by 
109 � 18%. Although ACh-induced inhibition of ICa,L 
was smaller in cells incubated in l-arginine (�11 � 
5%) compared with control cells (�21 � 5%), the dif-
ferences in these unpaired data did not reach statistical 
significance. Stimulation of ICa,L elicited by withdrawal 
of ACh, however, was significantly larger in l-arginine-
treated cells (109 � 18%) compared with control (49 � 
6%) (P � 0.05). To examine the stereo specificity of 
arginine, an additional experiment was performed 
where cells were incubated in 5 mM d-arginine. Cells 
117  Wang et al. incubated in d-arginine showed a 25% smaller rebound 
stimulation of ICa,L induced by ACh withdrawal than 
control cells from the same heart (n � 2). The results 
are consistent with the view that additional substrate 
(l-arginine) for NO signaling augmented the stimula-
tion of ICa,L elicited by withdrawal of ACh. In our previ-
ous study, we noted that the increase in ICa,L amplitude 
elicited by ACh withdrawal ranged between 5 and 
232% (SD � 49%; n � 53) in any given cell (Wang and 
Lipsius, 1995). Based on the present results, this vari-
ability in response could be due to the dependence of 
the rebound response on l-arginine concentration, 
which may vary in individual myocytes after isolation. 
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Figure 4.  Effect of W-7, a calmodulin inhibitor, 
on ACh-induced regulation of basal ICa,L. Under 
control conditions (A), exposure to and with-
drawal of 1 �M ACh elicited inhibition and re-
bound stimulation of ICa,L, respectively. After 4–5 
min, ICa,L recovered and stabilized (not shown). 
Exposure to 10 �M W-7 elicited a small decrease 
in ICa,L to the control level (B). In the presence of 
W-7, ACh inhibited ICa,L and rebound stimulation 
of ICa,L elicited by withdrawal of ACh was essen-
tially abolished. All recordings were obtained 
from the same cell. 
Histochemical Assay for NOS Activity 
So far, the results indicate that NO signaling underlies 
the stimulation of ICa,L elicited by withdrawal of ACh. In 
the next several experiments, we sought to determine 
whether atrial myocytes exhibit constitutive NOS activ-
ity, and whether exogenous NO stimulates ICa,L in a way 
similar to that elicited by withdrawal of ACh. In Fig. 6, 
A and B, we used a histochemical technique (NADPH-
diaphorase assay; Prabhakar et al., 1993) to demon-
strate the presence of NO synthase activity. Isolated 
atrial cells were fixed, permeabilized, and then incu-
bated in nitro blue tetrazolium in the absence or pres-
Figure 5.  Effect of l-arginine on ACh-induced 
regulation of ICa,L. In control cells (not incubated 
in l-arginine), ACh induced a typical inhibition 
followed by rebound stimulation of ICa,L elicited 
by ACh withdrawal (A). In another cell incubated 
in 5 mM l-arginine for 3 h, withdrawal of ACh 
elicited a significantly larger rebound stimulation 
of ICa,L (B). ence of �-NADPH. Cells prepared in the absence of 
�-NADPH (Fig. 6 A) failed to exhibit a positive staining 
reaction and those treated in the presence of �-NADPH 
stained positively (Fig. 6 B). Similar results were ob-
tained in cells isolated from three hearts. 
Effect of NO Donors on ICa,L 
Spermine NO (SP/NO) spontaneously releases NO 
without the production of other biologically active by-
products or intermediates (Maragos et al., 1991) and 
therefore was used in the present study as our typical 
NO donor. Fig. 7, A and B shows the effect of 100 �M 
SP/NO on original ICa,L recordings (A) and the cur-
rent–voltage relationship of ICa,L (B). As shown in Fig. 7 
A, SP/NO elicited a reversible increase in basal ICa,L 
amplitude (127%). SP/NO increased ICa,L throughout 
the voltage range and shifted peak ICa,L �5 mV more 
negative without affecting the reversal potential. Be-
cause SP/NO spontaneously releases NO and therefore 
decomposes to some extent over time (Maragos et al., 
1991), we thought the construction of a dose–response 
relationship would be quantitatively equivocal. How-
ever, to obtain a qualitative understanding of the ef-
fects of SP/NO, we tested different concentrations of 
SP/NO (0.3, 1, 30, 100, and 300 �M) on basal ICa,L am-
plitude. These experiments indicated that concentra-
tions of SP/NO � 1 �M have no significant effect on 
ICa,L and concentrations of SP/NO � 1 �M each elic-
ited consistent dose-dependent increases in ICa,L. Con-
centrations of SP/NO � 100 �M were essentially maxi-
mal. To ensure that the carrier compound, spermine, 
was not responsible for the observed effects of SP/NO, 
we tested 300 �M spermine alone and found no effect 
on ICa,L (n � 3) (not shown). These results indicate that 
NO stimulates basal ICa,L. Moreover, they support the 
results presented above that NO signaling mediates 
stimulation of ICa,L elicited by withdrawal of ACh. 
Effects of Hemoglobin and MnTBAP 
The experiments shown in Fig. 8, A and B were per-
formed to establish that the stimulatory effect of SP/ 
Figure 6.  Histochemical assay 
for NOS activity. Atrial myocytes 
were exposed to nitro blue tet-
razolium (NBT) in either the 
absence (A) or presence (B) of 
�-NADPH. In the presence of 
�-NADPH, NOS reduces tetrazo-
lium to formazan, a compound 
that appears as a dark stain. In 
the absence of �-NADPH (A), 
atrial cells appear clear (control) 
and in the presence of �-NADPH 
cells appear darkly stained, indi-
cating the presence of a constitu-
tive form of NOS activity. 
Figure 7.  Effect of spermine/NO on basal ICa,L (A) and the cur-
rent–voltage relationship of ICa,L  (B). Spermine/NO (100 �M) 
elicited a reversible increase in ICa,L amplitude throughout the volt-
age range, and shifted peak ICa,L to more negative voltages without 
affecting the reversal potential. The recovery of ICa,L after washout 
of spermine/NO is not shown in the current–voltage relationship 
for clarity. 
119  Wang et al. Figure 8.  Effects of hemoglobin (A) and MnTBAP (B) on spermine/NO-induced stimulation of basal ICa,L. Each graph shows consecu-
tive measurements of peak ICa,L amplitude recorded throughout an experiment. Spermine/NO (50 �M) elicited a sustained increase in 
ICa,L that was blocked by addition of 50 �M hemoglobin to the external spermine/NO-containing solution (A). Spermine/NO (50 �M) 
elicited a sustained increase in ICa,L (B). Addition of 50 �M MnTBAP failed to affect spermine/NO-induced stimulation of ICa,L. MnTBAP 
(50 �M) alone had no significant effect on basal ICa,L amplitude. 
NO on basal ICa,L is due to NO. As shown in Fig. 8 A, 50 
�M SP/NO elicited an increase in ICa,L that was main-
tained during exposure to SP/NO. Addition of 50 �M 
hemoglobin to the external solution inhibited the ef-
fects of SP/NO and returned ICa,L to control levels. 
When hemoglobin was removed in the continued pres-
ence of SP/NO, ICa,L increased once again (not shown), 
indicating that the effects of hemoglobin were revers-
ible. In a total of four cells tested, SP/NO alone in-
creased ICa,L by 61 � 11% and hemoglobin returned 
ICa,L to levels not different from control (P � 0.001). 
The fact that hemoglobin blocked the stimulation of 
ICa,L elicited by both exogenous NO and ACh with-
drawal supports the idea that both effects are mediated 
by a common mechanism; i.e., NO signaling. 
NO can react with oxygen free radicals to produce 
peroxynitrite, a biological active compound (Stamler et 
al., 1992b). Although SP/NO does not generate oxygen 
free radicals (Maragos et al., 1991), it is possible that 
oxygen free radicals produced endogenously may react 
with NO released by SP/NO to affect ICa,L. To examine 
this point, we tested SP/NO in the absence and pres-
ence of MnTBAP, a superoxide dismutase mimetic and 
peroxynitrite scavenger (Day et al., 1995; Szabo et al., 
1996). As shown in Fig. 8 B, exposure to 50 �M SP/NO 
elicited a sustained increase in ICa,L. Addition of 50 �M 
MnTBAP to the external solution failed to prevent the 
effects of SP/NO. In the three cells tested, SP/NO 
alone increased ICa,L by 54 � 17% and the addition of 
MnTBAP had no significant effect on ICa,L amplitude 
(56 � 17%). In four additional cells, MnTBAP alone 
exerted no significant effect on basal ICa,L amplitude. 
These findings, in conjunction with those presented in 
Fig. 8 A, suggest that SP/NO is acting via NO, and not 
peroxynitrite, to stimulate basal ICa,L. These results, 
however, do rule out the possibility that NO may form 
biologically active intermediates, such as S-nitrosothiols 
(Ignarro et al., 1981; Stamler et al., 1992a; Arnelle and 
Stamler, 1995), that may stimulate ICa,L, as reported in 
ferret ventricular myocytes (Campbell et al., 1996). In fer-
ret myocytes, however, the stimulatory effects of S-nitro-
sothiols were mediated by direct S-nitrosylation and/or 
disulfide reactions and not via second messenger sig-
naling mechanisms. The experiments presented below 
will establish that in cat atrial myocytes NO is acting via 
second messenger (cGMP) signaling. 
NO Stimulates ICa,L via Soluble Guanylate Cyclase 
The next question we addressed was whether exoge-
nous NO acts via soluble guanylate cyclase and the pro-
duction of cGMP. We therefore tested the effect of 
ODQ on SP/NO-induced stimulation of ICa,L. The orig-
inal records in Fig. 9 show the effects of 300 �M SP/ 
NO on ICa,L in the absence (control) and presence of 
30 �M ODQ. Under control conditions, SP/NO elic-
ited a marked increase in ICa,L (129%) that reversed on 
washout. In the presence of ODQ, the stimulatory ef-
fects of SP/NO on ICa,L were abolished. In a total of 
three cells tested, SP/NO increased ICa,L by 130 � 33% 
in the absence and by 15 � 6% in the presence of ODQ 
(P � 0.05). ODQ alone had little effect on ICa,L ampli-
tude. These experiments indicate that NO is acting via 
soluble guanylate cyclase and presumably cGMP to 
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the results presented above that NO acts via second 
messenger (cGMP) signaling to mediate stimulation of 
ICa,L elicited by withdrawal of ACh. 
NO Acts via Inhibition of PDE and Stimulation 
of cAMP/PKA 
Our previous study showed that milrinone, an inhibitor 
of PDE (type III) activity (Harrison et al., 1986) attenu-
ates rebound stimulation of ICa,L elicited by ACh with-
drawal (Wang and Lipsius, 1995). If SP/NO also is act-
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Figure 9.  Effect of ODQ on 
spermine/NO-induced stimula-
tion of basal ICa,L. Under control 
conditions (A), 300 �M sper-
mine/NO elicited a reversible in-
crease in ICa,L amplitude. In the 
presence of 30 �M ODQ (B), the 
effects of spermine/NO on ICa,L 
were abolished. All currents were 
recorded from the same cell. 
ing to stimulate ICa,L via inhibition of PDE (type III), 
then earlier stimulation of ICa,L by milrinone should 
prevent SP/NO from exerting any additional stimula-
tion of ICa,L. As shown in Fig. 10, 100 �M SP/NO stimu-
lated ICa,L (118%). Washout of SP/NO returned ICa,L to-
ward control. Exposure to 10 �M milrinone stimulated 
ICa,L to about the same extent as SP/NO (122%). This 
finding indicates that cat atrial myocytes express PDE 
(type III) activity, as reported previously (Wang and 
Lipsius, 1995). In the presence of milrinone, reexpo-
sure to SP/NO failed to further increase ICa,L, and, in 
fact, elicited a small inhibition of ICa,L (�17%). In all 
Figure 10.  Effect of spermine/ 
NO on ICa,L prestimulated by mil-
rinone, an inhibitor of PDE (type 
III) activity. Under control condi-
tions, spermine/NO (100 �M) 
stimulated basal ICa,L. After wash-
out of spermine/NO, exposure 
to 10 �M milrinone elicited a 
prominent increase in ICa,L. In 
the presence of milrinone, sper-
mine/NO failed to elicit an addi-
tional stimulation of ICa,L and, in 
fact, elicited a small inhibition of 
ICa,L. cells tested, SP/NO alone increased ICa,L by 117 � 6% 
(n � 3), milrinone alone increased ICa,L by 113 � 33% 
(n � 5), and the addition of SP/NO in the presence of 
milrinone failed to further stimulate ICa,L (�17 � 2%) 
(n � 5). Interpretation of these experiments is based 
on the premise that milrinone does not maximally stim-
ulate ICa,L. In this regard, we have previously reported 
in atrial myocytes that when ICa,L is prestimulated by 10 
�M milrinone, 1 �M isoproterenol elicits an additional 
increase in ICa,L of 101 � 26% (n � 5) (Wang and Lip-
sius, 1995), indicating that ICa,L is not maximally stimu-
lated by milrinone. These results, in conjunction with 
those described earlier, suggest that NO-cGMP signal-
ing acts to inhibit PDE (type III) activity and thereby 
stimulate basal ICa,L via elevation of cAMP. 
We previously reported that inhibition of cAMP-depen-
dent PKA activity abolishes rebound stimulation of ICa,L 
elicited by ACh withdrawal (Wang and Lipsius, 1995). 
To determine whether exogenous NO stimulates ICa,L 
via cAMP, SP/NO was tested in the absence and pres-
ence of H-89, an inhibitor of cAMP-dependent PKA ac-
tivity (Chijiwa et al., 1990). As shown in the bar graph 
in Fig. 11, 100 �M SP/NO elicited a mean increase in 
ICa,L of 108 � 35%. In the presence of 5 �M H-89, the 
stimulatory effect of SP/NO on ICa,L (36 � 7%) was sig-
nificantly reduced compared with control (P � 0.05; 
n � 5). In three additional cells, the concentration of 
SP/NO was lowered (30 �M) to a level that elicited an 
increase in ICa,L comparable to that achieved by ACh 
withdrawal. In the absence and presence of H-89, 30 
�M SP/NO elicited a mean increase in ICa,L of 61 � 5% 
and 14 � 5%, respectively (P � 0.001). These findings 
indicate that NO stimulates ICa,L primarily by increasing 
cAMP and are consistent with the role of NO signaling 
in stimulation of ICa,L elicited by ACh withdrawal. 
ACh-induced NO Signaling Is Pertussis Toxin–sensitive 
Previous findings indicate that pertussis toxin (PTX) 
blocks both ACh-induced inhibition and rebound stim-
ulation of ICa,L (Wang and Lipsius, 1995). Based on the 
present results, those findings indicate that PTX-sensi-
tive G-proteins mediate ACh-induced NO signaling 
mechanisms. To ensure that PTX does not interfere 
with steps in the NO signaling pathway downstream 
from G-protein sites, we tested the effects of 1 �M ACh, 
100 �M SP/NO, and 10 �M milrinone on atrial myo-
cytes incubated in PTX (3.4 �g/ml for 6 h; 36�C). As 
expected, in cells not incubated in PTX, ACh exposure 
and withdrawal elicited inhibition (�16 � 9%) and 
stimulation (124 � 32%) of ICa,L, respectively (n � 4), 
and SP/NO (208%; n � 2) and milrinone (137%; n � 
2) also stimulated ICa,L. In cells preincubated in PTX 
from the same hearts, the effects of ACh on ICa,L were 
abolished (n � 5), whereas SP/NO and milrinone still 
Figure 11.  Effect of H-89, an inhibitor of PKA, on spermine/ 
NO-induced stimulation of ICa,L. The graph shows the percent 
change in ICa,L amplitude elicited by either 100 �M spermine/NO 
(A) or 30 �M spermine/NO (B) in the absence (open bar) and 
presence (striped bar) of 5 �M H-89. Spermine/NO-induced stimu-
lation of ICa,L was significantly blocked by inhibition of PKA activity. 
In addition, H-89 exerted a more effective block at lower sper-
mine/NO concentrations. *P � 0.05; **P � 0.001. 
increased ICa,L by 117 � 35% and 99 � 41%, respec-
tively (n � 4). These results indicate that PTX does not 
interfere with NO signaling sites downstream from 
NOS, and suggests that PTX-sensitive G-proteins cou-
ple M2 muscarinic receptors to constitutive NOS. 
discussion 
In cat atrial myocytes, exposure to ACh inhibits basal 
ICa,L and withdrawal of ACh elicits rebound stimulation 
of ICa,L above control (Wang and Lipsius, 1995). Stimu-
lation of ICa,L elicited by ACh withdrawal was shown to 
involve ACh-induced inhibition of PDE (type III) activ-
ity. The present results extend our previous findings by 
demonstrating that ACh-induced modulation of PDE is 
mediated via NO-cGMP signaling and that this is the 
primary mechanism responsible for stimulation of ICa,L 
elicited by ACh withdrawal. Thus, pharmacological in-
terventions (hemoglobin, L-NIO, W-7, ODQ) that spe-
cifically block various steps in the NO-cGMP signaling 
pathway each blocked rebound stimulation of ICa,L, 
whereas interventions expected to enhance NO signal-
ing (incubation in l-arginine) enhanced stimulation of 
ICa,L elicited by ACh withdrawal. In addition, activation 
of NO signaling by exogenous NO (SP/NO) stimulated 
ICa,L, and its mechanism of action was essentially the 
same as that underlying the stimulation of ICa,L elicited 
by ACh withdrawal. In other words, SP/NO stimulated 
ICa,L via cGMP-induced inhibition of PDE (type III) ac-
tivity and elevation of cAMP. A similar mechanism has 
been reported for NO-induced stimulation of basal ICa,L 
in human atrial myocytes (Kirstein et al., 1995). The 
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atrial myocytes express a constitutive form of NOS ac-
tivity that can act as a substrate for the actions of ACh. 
The same histochemical staining method has been 
used to identify constitutive NOS in neuronal tissue 
(Hope et al., 1991) and cardiac ventricular myocytes 
(Zakharov et al., 1996). More specific methods of im-
munohistochemistry, Northern blot analysis, or in situ 
hybridization have revealed eNOS in human atrial tis-
sue (Wei et al., 1996), rat atrial (Seki et al., 1996), and 
rabbit AV nodal cells (Han et al., 1996). It is interesting 
to note that in guinea pig ventricular myocytes, with-
drawal of ACh also elicits rebound stimulation of 
cAMP-regulated chloride current (Zakharov and Har-
vey, 1997). However, even though these cells express 
constitutive NO synthase activity (Zakharov et al., 
1996), ACh-induced rebound stimulation of chloride 
current does not involve NO-cGMP signaling mecha-
nisms (Zakharov and Harvey, 1997). 
The present findings also indicate that NO-cGMP sig-
naling does not contribute to ACh-induced inhibition 
of basal ICa,L. Thus, none of the drugs that blocked NO 
signaling and rebound stimulation of ICa,L prevented 
ACh-induced inhibition of ICa,L. This finding provides 
further evidence that NO signaling plays a specific role 
in stimulation of basal ICa,L elicited by ACh withdrawal. 
In our previous study, we reported preliminary experi-
ments where L-NMMA, an inhibitor of NOS activity, 
blocked ACh-induced inhibition of ICa,L, suggesting 
that NO signaling may play a role in ACh-induced inhi-
bition of basal ICa,L (Wang and Lipsius, 1995). Clearly, 
that finding is not supported by the weight of evidence 
obtained in the present study. To reexamine the role of 
NOS in ACh-induced regulation of ICa,L, we found in 
the present study that the NOS blocker L-NIO did not 
prevent ACh-induced inhibition of ICa,L, although it 
abolished stimulation of ICa,L elicited by ACh with-
drawal. Moreover, the fact that elevated levels of l-argi-
nine restored ACh-induced stimulation of ICa,L indi-
cates that L-NIO acted specifically to inhibit NOS. 
These results are consistent with all the other findings 
in this study, which indicate that NO signaling does not 
play a role in ACh-induced inhibition of basal ICa,L. 
Others have reported that NO signaling plays a critical 
role in the inhibitory effects of ACh on cardiac ICa,L 
(Mery et al., 1991, 1993; Han et al., 1994, 1995, 1996; 
Levi et al., 1994; Wahler and Dollinger, 1995; Balligand 
et al., 1995). However, this inhibitory effect of NO sig-
naling is obtained only when ICa,L is prestimulated by el-
evated cAMP. Under these conditions, NO-cGMP sig-
naling is thought to inhibit ICa,L via stimulation of PDE 
(Han et al., 1995, 1996) or activation of PKG activity 
(Mery et al., 1991; Levi et al., 1994; Wahler and Doll-
inger, 1995). Neither of these NO signaling mecha-
nisms appear to play a role in ACh-induced inhibition 
of basal ICa,L in cat atrial myocytes. We have found, how-
ever, that when ICa,L is prestimulated by isoproterenol, 
SP/NO inhibits rather than stimulates ICa,L in cat atrial 
myocytes (our unpublished observations). This finding 
may explain the present observation that SP/NO inhib-
ited ICa,L in cells prestimulated by milrinone (Fig. 10), 
which acts by raising cAMP. 
In the present experiments, ACh-induced inhibition 
of basal ICa,L is evident (even enhanced) in the presence 
of methylene blue in the external solutions. In rabbit SA 
node pacemaker cells (Han et al., 1995), external applica-
tion of methylene blue blocked ACh-induced inhibition 
of prestimulated ICa,L as well as ACh-induced activation of 
K� current. However, when applied intracellularly, meth-
ylene  blue only blocked ACh-induced inhibition of 
ICa,L. From these findings, it was concluded that methy-
lene blue blocks muscarinic receptors. A similar find-
ing has been reported in rat ventricular myocytes (Abi 
Gerges et al., 1997). The present results indicate that in 
cat atrial myocytes methylene blue does not block mus-
carinic receptors. It may be that methylene blue exerts 
nonspecific receptor blocking effects that are species 
dependent. Another interesting aspect of these experi-
ments is that methylene blue very effectively blocked the 
stimulation of ICa,L elicited by ACh withdrawal even 
though it is considered a weak inhibitor of soluble guany-
late cyclase activity. This may be explained by the fact that 
methylene blue also is reported to inhibit NOS (Mayer et 
al., 1993), and therefore may act to block two critical sites 
in the NO signaling pathway activated by ACh. 
Each of the pharmacological compounds used in the 
present study to manipulate different steps in the NO 
signaling pathway exerted some direct effects on ICa,L. 
These effects could be interpreted to indicate that 
these cells produce endogenous levels of NO that 
could potentially modulate basal ICa,L. However, even 
though ICa,L stabilized after the initial ACh exposure 
peak, ICa,L generally did not fully recover to control lev-
els, indicating some residual stimulatory effects of ACh. 
Therefore, ICa,L was not in a true basal state during the 
administration of each test compound. Those NO-
blocking compounds that inhibited ICa,L returned ICa,L 
amplitude to control baseline values. Their actions, 
therefore, could be interpreted as blocking the residual 
NO-induced stimulatory effects exerted by the initial 
ACh exposure. However, other compounds that blocked 
NO signaling exerted small stimulatory effects on ICa,L. 
Their actions are less clear and may involve more com-
plex effects on ICa,L. In any case, these experiments 
were not designed to examine the direct effects of 
these drugs on basal NO signaling mechanisms. More-
over, regardless of the direct drug effects, the results of 
these experiments are consistent with the conclusions 
that NO signaling mediates rebound stimulation of ICa,L 
elicited by ACh withdrawal. 
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1995), the present results suggest that exposure to ACh 
acts via M2 muscarinic receptors coupled to PTX-sensi-
tive G-proteins to inhibit basal ICa,L, primarily via inhibi-
tion of the adenylate cyclase/cAMP/PKA cascade. At 
the same time, ACh acts via PTX-sensitive G-proteins 
coupled to constitutive NOS to elicit NO-cGMP-induced 
inhibition of PDE (type III) activity. Upon withdrawal 
of ACh from the receptor, we speculate that adenylate 
cyclase/cAMP activity recovers more rapidly than PDE 
activity, resulting in an increase in cAMP above baseline 
and rebound stimulation of ICa,L. These findings are sup-
ported by direct measurements of cAMP in chick heart 
cells where withdrawal of cholinergic agonist acts via 
PTX-sensitive G-proteins to elicit rebound stimulation 
of adenylate cyclase activity and increases in cAMP con-
centrations above control levels (Linden, 1987). 
Functionally, ICa,L plays a critical role in the regula-
tion of cardiac pacemaker and contractile activities. In 
fact, rebound stimulation of ICa,L elicited by ACh with-
drawal stimulates SA node pacemaker cell rate (Wang 
and Lipsius, 1996) and atrial cell contraction (Wang 
and Lipsius, 1995) above control levels. Rebound stim-
ulation of ICa,L elicited by ACh withdrawal also has been 
reported in catecholamine-treated Purkinje fibers (Ehara 
and Mitsuiye, 1984). This stimulatory effect of ACh on 
ICa,L probably serves to rapidly restore cardiac pace-
maker and contractile functions after periods of cholin-
ergic suppression. Moreover, background �-adrenergic 
stimulation augments rebound stimulation of cAMP 
(Linden, 1987) and ICa,L (Wang and Lipsius, 1995). This 
suggests that in the presence of �-adrenergic stimula-
tion NO signaling may mediate both enhanced ACh-
induced inhibition of ICa,L (i.e., accentuated antago-
nism) and enhanced rebound stimulation of ICa,L. In 
addition to stimulating Ca2� influx via ICa,L, ACh-induced 
stimulation of cAMP stimulates Ca2� uptake into the 
sarcoplasmic reticulum (Wang et al., 1997). By loading 
intracellular Ca2� stores, withdrawal of ACh can Ca2� 
overload the sarcoplasmic reticulum, thereby eliciting 
Ca2�-mediated delayed afterdepolarizations and spon-
taneous/triggered atrial activities (Wang et al., 1997). 
This arrhythmogenic aspect of ACh withdrawal may be 
enhanced by other preexisting conditions that raise in-
tracellular Ca2�. This suggests that the NO signaling 
mechanisms presented here may contribute to vagally 
induced Ca2�-mediated atrial dysrhythmias. NO signal-
ing, therefore, may be a potential target for antiar-
rhythmic drug therapies. The relevance of the present 
results to human cardiac function is emphasized by the 
fact that basal ICa,L in cat atrial myocytes and human 
atrial myocytes (Kirstein et al., 1995) exhibit similar 
stimulatory responses to NO signaling. Whether human 
atrial myocytes exhibit similar responses to ACh re-
mains to be determined. 
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